• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

CDC Calls Continued Rise in Cases of STIs “Alarming”

CDC Calls Continued Rise in Cases of STIs “Alarming”

by Miriam Bergeret, MSc | May 5, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.

This content is for Paid Members only.
Login Register
The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations

The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations

by Glenn S. Demby | Apr 24, 2023 | Diagnostic Testing and Emerging Technologies, FDA-dtet

On March 27, the agency released a new guidance document to help test developers make the transition to full approval.

This content is for Paid Members only.
Login Register
Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

by Glenn S. Demby | Apr 17, 2023 | News

Group of 18 senators says ending Medicare coverage for at-home COVID-19 tests would undo efforts to contain spread of the coronavirus.

Medical Device Executives Nailed with Fraud Charges

Medical Device Executives Nailed with Fraud Charges

by Rachel Muenz | Apr 12, 2023 | News

The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

by Glenn S. Demby | Jan 26, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com